glp 1 vs retatrutide vs. Tirzepatide: The New Contender vs. the Current Leader Retatrutide vs. Ozempic: The Triple

References Kimura H, Takeda K, Tsuruya K et al (2010) Left ventricular mass index is an independent determinant of diastolic dysfunction in patients on chronic hemodialysis: a tissue Doppler imaging study

The GLP-1 Bridge covers three medications for weight reduction and maintenance: Foundayo (all formulations) Wegovy (injection and tablets, all formulations) Zepbound KwikPen (KwikPen formulation only) Note that Ozempic and Mounjaro are not included in the Bridge program, since those are the diabetes-indicated versions

.

Endocrinol., vol

Problems with balance or coordination

FDA labels and approvals for semaglutide, liraglutide, dulaglutide, exenatide, lixisenatide, and tirzepatide (including obesity and OSA indications)